Enzo Biochem (NYSE:ENZ) Share Price Crosses Above 200-Day Moving Average of $1.14

Enzo Biochem, Inc. (NYSE:ENZ) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.14 and traded as high as $1.14. Enzo Biochem shares last traded at $1.14, with a volume of 49,919 shares.

Enzo Biochem Stock Performance

The firm has a 50 day moving average price of $1.12 and a 200-day moving average price of $1.14.

Hedge Funds Weigh In On Enzo Biochem

Several large investors have recently made changes to their positions in the business. XTX Topco Ltd lifted its position in shares of Enzo Biochem by 94.5% during the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after purchasing an additional 13,735 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares in the last quarter. Finally, Wittenberg Investment Management Inc. acquired a new position in shares of Enzo Biochem in the 4th quarter worth approximately $95,000. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.